Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 02, 2022

SELL
$80.52 - $93.75 $202,668 - $235,968
-2,517 Closed
0 $0
Q4 2021

Jan 27, 2022

SELL
$79.7 - $88.13 $192,156 - $212,481
-2,411 Reduced 48.92%
2,517 $221,000
Q3 2021

Nov 12, 2021

BUY
$81.78 - $95.14 $187,848 - $218,536
2,297 Added 87.31%
4,928 $401,000
Q2 2021

Jul 29, 2021

BUY
$85.24 - $94.15 $224,266 - $247,708
2,631 New
2,631 $240,000
Q1 2021

May 14, 2021

SELL
$83.5 - $98.47 $254,758 - $300,431
-3,051 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$78.07 - $94.43 $31,227 - $37,772
400 Added 15.09%
3,051 $288,000
Q2 2020

Aug 14, 2020

SELL
$80.93 - $91.1 $11,734 - $13,209
-145 Reduced 5.19%
2,651 $233,000
Q1 2020

May 14, 2020

BUY
$70.67 - $99.01 $25,087 - $35,148
355 Added 14.54%
2,796 $241,000
Q4 2019

Feb 14, 2020

SELL
$84.35 - $95.37 $12,399 - $14,019
-147 Reduced 5.68%
2,441 $231,000
Q3 2019

Nov 14, 2019

SELL
$85.54 - $94.26 $256 - $282
-3 Reduced 0.12%
2,588 $227,000
Q2 2019

Aug 12, 2019

SELL
$75.4 - $92.8 $78,114 - $96,140
-1,036 Reduced 28.56%
2,591 $236,000
Q1 2019

May 14, 2019

SELL
$75.32 - $86.15 $13,180 - $15,076
-175 Reduced 4.6%
3,627 $349,000
Q4 2018

Feb 13, 2019

SELL
$73.66 - $82.02 $35,356 - $39,369
-480 Reduced 11.21%
3,802 $320,000
Q3 2018

Nov 13, 2018

SELL
$66.94 - $77.43 $8,099 - $9,369
-121 Reduced 2.75%
4,282 $373,000
Q2 2018

Aug 03, 2018

SELL
$64.91 - $73.36 $92,496 - $104,538
-1,425 Reduced 24.45%
4,403 $333,000
Q1 2018

May 14, 2018

BUY
$70.39 - $84.15 $27,804 - $33,239
395 Added 7.27%
5,828 $471,000
Q4 2017

Feb 12, 2018

SELL
$72.33 - $77.64 $18,154 - $19,487
-251 Reduced 4.42%
5,433 $457,000
Q3 2017

Nov 03, 2017

BUY
$74.14 - $77.27 $12,455 - $12,981
168 Added 3.05%
5,684 $489,000
Q2 2017

Aug 14, 2017

BUY
N/A
5,516
5,516 $460,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $233B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Brown Advisory Securities, LLC Portfolio

Follow Brown Advisory Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Securities, LLC with notifications on news.